News and Events
Stay up to date with news and events
Decoding apathy in Huntington’s disease: a new lens on motivation and decision-making
Many people living with Huntington’s disease (HD) lose motivation to carry out some tasks. A new study shows that these apathetic behaviors are because of…
2024: Year in Review
As we wave goodbye to 2024, the HDBuzz team reflects on a year marked by significant progress, challenges, and hope. From breakthroughs at the lab…
2024 HDBuzz Prize: A NEAT new dance partner for Huntingtin
Proteins are like molecular dancers, with the cell acting as their dance floor. Proteins pair up with various partners to perform elaborate dances. Depending on…
Beta-blockers associated with delayed onset and decreased progression of Huntington’s disease
Research led by Dr. Peg Nopoulos from the University of Iowa used the Enroll-HD database to answer a key question: “How does beta-blocker use influence…
Interim update from Vico Therapeutics on their CAG-targeting drug, VO659
Vico Therapeutics recently presented at several conferences to share an interim update on their Phase 1/2a clinical trial testing their drug called VO659, which targets…